905281-60-9 Usage
Uses
Used in Coordination Chemistry:
4-(1-Methyl-1H-pyrazol-5-yl)pyridine is used as a ligand for the formation of coordination compounds. Its ability to chelate with metal ions allows for the creation of complexes with unique properties and potential applications in various fields.
Used in Organic Synthesis:
In the field of organic synthesis, 4-(1-Methyl-1H-pyrazol-5-yl)pyridine is used as a building block for the assembly of more complex organic molecules. Its versatile structure enables the synthesis of a wide range of compounds with potential applications in pharmaceuticals, materials science, and other areas.
Used in Pharmaceutical Research:
4-(1-Methyl-1H-pyrazol-5-yl)pyridine is used as a pharmaceutical intermediate due to its potential biological activity. Its unique structure allows for the development of new drugs with specific therapeutic properties, making it a valuable component in the discovery and design of novel pharmaceutical agents.
Used in Research and Development:
In the research and development industry, 4-(1-Methyl-1H-pyrazol-5-yl)pyridine is utilized for studying its potential applications and properties. Its unique structure and properties make it an interesting subject for scientific investigation, leading to a better understanding of its potential uses and benefits in various fields.
Check Digit Verification of cas no
The CAS Registry Mumber 905281-60-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,0,5,2,8 and 1 respectively; the second part has 2 digits, 6 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 905281-60:
(8*9)+(7*0)+(6*5)+(5*2)+(4*8)+(3*1)+(2*6)+(1*0)=159
159 % 10 = 9
So 905281-60-9 is a valid CAS Registry Number.
905281-60-9Relevant articles and documents
RAF INHIBITOR COMPOUNDS AND METHODS
-
Page/Page column 74, (2008/06/13)
Pyrazolyl compounds of Formulas Ia and Ib are useful for inhibiting Raf kinase and for treating disorders mediated thereby. Methods of using pyrazolyl compounds for in vitro, in situ, and in vivo diagnosis, prevention or treatment of such disorders in mammalian cells, or associated pathological conditions are disclosed.
